310 related articles for article (PubMed ID: 9794366)
21. Sublingual vaccination with sonicated Salmonella proteins and mucosal adjuvant induces mucosal and systemic immunity and protects mice from lethal enteritis.
Huang CF; Wu TC; Wu CC; Lee CC; Lo WT; Hwang KS; Hsu ML; Peng HJ
APMIS; 2011 Jul; 119(7):468-78. PubMed ID: 21635554
[TBL] [Abstract][Full Text] [Related]
22. Immunostimulatory DNA is a potent mucosal adjuvant.
Horner AA; Ronaghy A; Cheng PM; Nguyen MD; Cho HJ; Broide D; Raz E
Cell Immunol; 1998 Nov; 190(1):77-82. PubMed ID: 9826449
[TBL] [Abstract][Full Text] [Related]
23. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
McCluskie MJ; Weeratna RD; Davis HL
Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
[TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.
Xue G; Yu L; Li S; Shen X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341
[TBL] [Abstract][Full Text] [Related]
25. Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes.
McCluskie MJ; Wen YM; Di Q; Davis HL
Viral Immunol; 1998; 11(4):245-52. PubMed ID: 10189191
[TBL] [Abstract][Full Text] [Related]
26. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
27. Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Bos GW; Kanellos T; Crommelin DJ; Hennink WE; Howard CR
Vaccine; 2004 Dec; 23(4):460-9. PubMed ID: 15530694
[TBL] [Abstract][Full Text] [Related]
28. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
[TBL] [Abstract][Full Text] [Related]
29. CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.
Qin W; Jiang J; Chen Q; Yang N; Wang Y; Wei X; Ou R
Cell Mol Immunol; 2004 Apr; 1(2):148-52. PubMed ID: 16212903
[TBL] [Abstract][Full Text] [Related]
30. Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.
Sasaki K; Kato M; Takahashi T; Ochi S; Ichinose Y; Shiraki K; Asano Y; Iwanaga M; Tsuji T
J Med Virol; 2003 Jun; 70(2):329-35. PubMed ID: 12696126
[TBL] [Abstract][Full Text] [Related]
31. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
32. Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model.
Alcón VL; Baca-Estrada M; Vega-López MA; Willson P; Babiuk LA; Kumar P; Foldvari M
J Pharm Pharmacol; 2005 Aug; 57(8):955-62. PubMed ID: 16102250
[TBL] [Abstract][Full Text] [Related]
33. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
34. T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides.
Zhou X; Zheng L; Liu L; Xiang L; Yuan Z
Scand J Immunol; 2003 Sep; 58(3):350-7. PubMed ID: 12950682
[TBL] [Abstract][Full Text] [Related]
35. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.
Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z
Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361
[TBL] [Abstract][Full Text] [Related]
36. Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.
Yanagita M; Hiroi T; Kitagaki N; Hamada S; Ito HO; Shimauchi H; Murakami S; Okada H; Kiyono H
J Immunol; 1999 Mar; 162(6):3559-65. PubMed ID: 10092814
[TBL] [Abstract][Full Text] [Related]
37. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
[TBL] [Abstract][Full Text] [Related]
38. CpG DNA as mucosal adjuvant.
McCluskie MJ; Davis HL
Vaccine; 1999 Sep; 18(3-4):231-7. PubMed ID: 10506647
[TBL] [Abstract][Full Text] [Related]
39. Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants.
McCluskie MJ; Davis HL
Vaccine; 2000 Oct; 19(4-5):413-22. PubMed ID: 11027803
[TBL] [Abstract][Full Text] [Related]
40. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12.
Schirmbeck R; Reimann J
Intervirology; 2001; 44(2-3):115-23. PubMed ID: 11509872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
